Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Illinois CancerCare, P.C., one of the largest community oncology and hematology practices in Illinois with 14 clinic locations. Illinois CancerCare will deploy Canopy’s comprehensive platform, including Remote Therapeutic Monitoring and oncology-specific AI for patient services.
Read more
Canopy, the leader in Enterprise AI for oncology, announced today that it has been named to the 2026 New York Digital Health 100 (DH100) for the third consecutive year, an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Canopy helps cancer centers manage the growing complexity of care by providing an Enterprise AI platform across patient services: triage, call center, front office, referrals, and pharmacy. By embedding AI and automation into existing workflows, Canopy enables faster issue resolution for patients, reduces manual work for staff, and helps practices capture sustainable reimbursement for this care.
Read more.png)
Canopy, the leader in Enterprise AI for oncology, today announced a partnership with the University of South Alabama (USA) Health Mitchell Cancer Institute, an academic research and treatment facility in Mobile, Alabama, to transform patient support between visits. USA Health selected Canopy’s AI-native platform to replace legacy systems, aiming to extend the benefits of Remote Therapeutic Monitoring (RTM) across increasingly complex therapies while reducing operational burden for staff.
Read more.png)
Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Utah Cancer Specialists (UCS), the largest community-based oncology and hematology practice in Utah and a member of the ONCare Alliance, to modernize how care teams support patients between visits. UCS selected Canopy to replace legacy systems with an AI-native solution that keeps pace with the needs of their patients and staff while building scalable programs for Remote Therapeutic Monitoring (RTM) and Care Management (CCM/PCM).
Read more
New data demonstrate the potential of Canopy's Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing serious infections in patients with hematologic malignancies, resulting in an estimated $977,695 in annual savings per 1,000 patients. Canopy, the leader in Enterprise AI for oncology, today announced new findings that highlight how its RTM Platform strengthens outpatient care and reduces infection-related escalations in patients with hematological malignancies.
Read moreStudy shows potential of Canopy’s Remote Therapeutic Monitoring Platform to reduce infection-related hospitalizations and ER visits in patients treated for hematological malignancy New York, New York - Canopy, the leader in Enterprise AI for oncology, today announced findings on the potential of its EHR-integrated Remote Therapeutic Monitoring (RTM) Platform to reduce infection-related hospitalization in patients receiving treatment for hematologic malignancies, through earlier identification of infection-related symptoms and associated initiation of outpatient oral antibiotics.
Read more
Jan 01 2023
Nov 07 2022
Sep 06 2022
Mar 19 2022
Mar 18 2022
Mar 17 2022
Mar 17 2022
